Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solitary Kidney”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00556049
What this trial is testing

Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaNeoplasm Metastases
Massachusetts General Hospital 72
Early research (Phase 1)UnknownNCT04126538
What this trial is testing

Pirfenidone Capsule in Patients With Chronic Kidney Disease G2 and G3a Study on Safety and Pharmacokinetics

Who this might be right for
Renal Insufficiency
Beijing Continent Pharmaceutical Co, Ltd. 24
Early research (Phase 1)Study completedNCT04178447
What this trial is testing

Pharmacokinetic Profile of Glepaglutide After a Single Injection in Subjects With Varying Degrees of Renal Function

Who this might be right for
Renal Impairment
Zealand Pharma 16
Testing effectiveness (Phase 2)Study completedNCT00264433
What this trial is testing

The Safety and Effects of ADH-1 Given Intravenously as a Single Agent

Who this might be right for
Neoplasms
Adherex Technologies, Inc.
Not applicableUnknownNCT04808011
What this trial is testing

A Single Arm, Multi-Center Study To Evaluate The Intelligent Dialysis Assistant (IDA)

Who this might be right for
Chronic Kidney Disease Stage 5
liberDi Ltd. 20
Testing effectiveness (Phase 2)Looking for participantsNCT07050771
What this trial is testing

Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery

Who this might be right for
Hepatopancreaticobiliary (HPB) MalignancyOvarian Cancer (OvCa)Kidney Cancers+1 more
The Methodist Hospital Research Institute 148
Testing effectiveness (Phase 2)UnknownNCT03601780
What this trial is testing

Local Wound Infiltration in Renal Surgery

Who this might be right for
Postoperative Pain
Assiut University 40
Early research (Phase 1)Study completedNCT02199379
What this trial is testing

A Phase 1, Open-Label, Single-Dose, Pharmacokinetic and Safety Study of E7080 (24 mg) Administered to Subjects With Mild, Moderate, and Severe Renal Impairment and to Healthy Subjects

Who this might be right for
Renal ImpairmentDisease Severity
Eisai Inc. 26
Early research (Phase 1)Study completedNCT02560220
What this trial is testing

MIC Cell Therapy for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients

Who this might be right for
Kidney Failure, Chronic
Heidelberg University 14
Large-scale testing (Phase 3)Looking for participantsNCT07197580
What this trial is testing

Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC

Who this might be right for
ccRCCRenal Cell Carcinoma (Kidney Cancer)Renal Cell Carcinoma (RCC)+3 more
Telix Pharmaceuticals (Innovations) Pty Limited 40
Testing effectiveness (Phase 2)WithdrawnNCT01070186
What this trial is testing

Study of Sunitinib in Subjects With High Risk Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Jonsson Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT01932970
What this trial is testing

Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to Etelcalcetide

Who this might be right for
Hyperparathyroidism, Secondary
Amgen 158
Early research (Phase 1)Study completedNCT00935831
What this trial is testing

Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment

Who this might be right for
Kidney Disease
GlaxoSmithKline 12
Not applicableStudy completedNCT01496703
What this trial is testing

Reasons for Mycophenolate Mofetil Dose Reduction and Impact on Graft Outcome in Renal Transplant Recipients

Who this might be right for
Acute Rejection of Renal TransplantRenal Graft Loss
Universitaire Ziekenhuizen KU Leuven 749
Large-scale testing (Phase 3)Ended earlyNCT05786469
What this trial is testing

Patiromer Trial in CKD Stage IIIB to V

Who this might be right for
Hyperkalemia
Mario Negri Institute for Pharmacological Research 2
Early research (Phase 1)Study completedNCT04148937
What this trial is testing

The CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer

Who this might be right for
Advanced Cancer
Eli Lilly and Company 52
Testing effectiveness (Phase 2)WithdrawnNCT02397395
What this trial is testing

An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis.

Who this might be right for
Renal ImpairmentEnd-stage Renal Disease
Janssen R&D Ireland
Early research (Phase 1)Study completedNCT00933972
What this trial is testing

RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairment

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 36
Early research (Phase 1)Study completedNCT00478725
What this trial is testing

Part A: Radiolabel Study With GW786034 Part B: Single Dose of GW786034

Who this might be right for
Carcinoma, Renal Cell
GlaxoSmithKline 10
Early research (Phase 1)Study completedNCT01407276
What this trial is testing

Omarigliptin (MK-3102) in Participants With Impaired Renal Function (MK-3102-009)

Who this might be right for
Chronic Renal InsufficiencyType 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 49
Next Page